Detailansicht

Wissensnetz

Person

Florin-Andrei Ţăran (1978-)

Gynäkologe

Name	Florin-Andrei Ţăran
Zeit	1978- (Lebensdaten)
Ort	Timişoara (Geburtsort) Deutschland
Beruf	Gynäkologe (charakteristischer Beruf)
Variante	Florin Andrei Taran F. Andrei Taran Florin Taran Andrei Taran
Beziehung	Bernhard Krämer (berufliche Beziehung)
Weitere Angaben	Habil.-Schr. an der Medizinischen Fakultät (Fach Frauenheilkunde und Geburtshilfe) der Universität Tübingen, 2012
Datensatztyp	Person
GND-Nummer	13392792X
Datensatz-ID	13392792X
Beteiligt an alle anzeigen Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer Novel Antibody-Drug-Conjugates in Routine Clinical Practice for the Treatment of Metastatic Breast Cancer: Adherence, Efficacy and Tolerability – Real-World Data from German Breast Centers Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry CDK4/6 Inhibition – Therapy Sequences and the Quest to Find the Best Biomarkers – an Overview of Current Programs Surgical Procedures for the Treatment of Stress Urinary Incontinence (SUI) in the Light of the Updated FDA-Warning and its Effects on Practice Patterns in Germany between 2010 and 2021 Attrition in the first three therapy lines in patients with advanced breast cancer in the German real-world PRAEGNANT registry CDK4/6 inhibition – therapy sequences and the quest to find the best biomarkers – an overview of current programs = CDK4/6-Inhibition: Sequenztherapien und die Suche nach den besten Biomarkern – ein Überblick über die aktuellen Programme Comparing the HER2 status of the primary tumor to that of disseminated tumor cells in early breast cancer Feasibility of targeted therapies in the adjuvant setting of early breast cancer in men: real-world data from a population-based registry Implementation and evaluation of a breast cancer disease model using real-world claims data in Germany from 2010 to 2020 Novel antibody-drug-conjugates in routine clinical practice for the treatment of metastatic breast cancer: adherence, efficacy and tolerability - real-world data from German breast centers = Neue Antikörper-Wirkstoff-Konjugate in der klinischen Praxis zur Behandlung von metastatischem Brustkrebs: Therapieadhärenz, Wirksamkeit und Verträglichkeit - Real-World-Daten aus deutschen Krebszentren Surgical procedures for the treatment of stress urinary incontinence (SUI) in the light of the updated FDA-warning and its effects on practice patterns in Germany between 2010 and 2021 Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patients—a multicenter real-world analysis The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype The value of a multimodal approach combining radical surgery and intraoperative radiotherapy in the recurrence treatment of gynecological malignancies - analysis of a large patient cohort in a tertiary care center Update Mammakarzinom 2024 Teil 1 – Expertenmeinungen zu Brustkrebs in fortgeschrittenen Krankheitsstadien = Update breast cancer 2024 part 1 – expert opinion on advanced breast cancer Diagnostic performance of additional imaging tests for staging purposes in a bicentric German series of low-risk early breast cancer patients Solitary precaval right renal artery and bilateral double ureter in a patient with high-grade serous ovarian cancer Update Breast Cancer 2023 Part 3 – Expert Opinions of Early Stage Breast Cancer Therapies Update Breast Cancer 2023 Part 2 – Advanced-Stage Breast Cancer Update Breast Cancer 2023 Part 1 – Early Stage Breast Cancer Association between 21-gene-assay and detection of disseminated tumor cells in patients with early breast cancer: results from the IRMA trial Characteristics, treatment patterns and survival of international federation of gynecology and obstetrics stage IV epithelial ovarian cancer - a population-based study Diagnostic performance of additional imaging tests for staging purposes in a bicentric German series of low-risk early breast cancer patients Evolving trends in the surgical therapy of patients with endometrial cancer in Germany: analysis of a nationwide registry with special emphasis on perioperative outcomes Solitary precaval right renal artery and bilateral double ureter in a patient with high-grade serous ovarian cancer The clinical relevance of the NATALEE study: application of the NATALEE criteria to a real-world cohort from two large German breast cancer centers Tumor-free resection margin distance in the surgical treatment of node-negative squamous cell cancer of the vulva has no impact on survival: analysis of a large patient cohort in a tertiary care center Update breast cancer 2023 Part 1 – early stage breast cancer Update breast cancer 2023 Part 1: early stage breast cancer Update breast cancer 2023 part 2 – advanced-stage breast cancer Update breast cancer 2023 part 2: advanced-stage breast cancer Update breast cancer 2023 Part 3 – expert opinions of early stage breast cancer therapies Update breast cancer 2023 part 3: expert opinions of early stage breast cancer therapies Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT Implementation of CDK4/6 inhibitors and its influence on the treatment landscape of advanced breast cancer patients – data from the real-world registry PRAEGNANT = Einführung von CDK4/6-Hemmern und deren Auswirkung auf die Behandlungslandschaft bei Patientinnen mit Brustkrebs im fortgeschrittenen Stadium – Real-World-Daten aus dem PRAEGNANT-Register Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics – a retrospective analysis of a real world registry Recurrence Score® result impacts treatment decisions in hormone receptor-positive, HER2-negative patients with early breast cancer in a real-world setting - results of the IRMA trial Status of Sentinel Lymph Node Biopsy in Endometrial Cancer Status of sentinel lymph node biopsy in endometrial cancer = Stellenwert der Sentinellymphonodektomie beim Endometriumkarzinom Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis Das männliche Mammakarzinom : Vergleich der diagnostischen Wertigkeit von Palpation, Sonografie und Mammografie Die laparoskopische suprazervikale Hysterektomie mit und ohne Peritonealisierung Update Breast Cancer 2018 (Part 1) – Primary Breast Cancer and Biomarkers Gynäkologische Onkologie : Prolog für die DKG: Olaf Ortmann, Geleitwort für die DGS: Rüdiger Schulz-Wendtland, Prolog für die AGO: Tanja Fehm Detection and clinical relevance of hematogenous tumor cell dissemination in patients with ductal carcinoma in situ Benign and Borderlinelesions of the myometrium : dissecting the clinical phenotype and developing new diagnostic and therapeutic tools Expression der Mismatch-Reparatur-Proteine und Mikrosatelliteninstabilität in Urothelkarzinomen

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Florin-Andrei Ţăran (1978-)

Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer

Novel Antibody-Drug-Conjugates in Routine Clinical Practice for the Treatment of Metastatic Breast Cancer: Adherence, Efficacy and Tolerability – Real-World Data from German Breast Centers

Attrition in the First Three Therapy Lines in Patients with Advanced Breast Cancer in the German Real-World PRAEGNANT Registry

CDK4/6 Inhibition – Therapy Sequences and the Quest to Find the Best Biomarkers – an Overview of Current Programs

Surgical Procedures for the Treatment of Stress Urinary Incontinence (SUI) in the Light of the Updated FDA-Warning and its Effects on Practice Patterns in Germany between 2010 and 2021

Attrition in the first three therapy lines in patients with advanced breast cancer in the German real-world PRAEGNANT registry

CDK4/6 inhibition – therapy sequences and the quest to find the best biomarkers – an overview of current programs = CDK4/6-Inhibition: Sequenztherapien und die Suche nach den besten Biomarkern – ein Überblick über die aktuellen Programme

Comparing the HER2 status of the primary tumor to that of disseminated tumor cells in early breast cancer

Feasibility of targeted therapies in the adjuvant setting of early breast cancer in men: real-world data from a population-based registry

Implementation and evaluation of a breast cancer disease model using real-world claims data in Germany from 2010 to 2020

Surgical procedures for the treatment of stress urinary incontinence (SUI) in the light of the updated FDA-warning and its effects on practice patterns in Germany between 2010 and 2021

Susceptibility gene mutations in germline and tumors of patients with HER2-negative advanced breast cancer

The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patients—a multicenter real-world analysis

The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype

The value of a multimodal approach combining radical surgery and intraoperative radiotherapy in the recurrence treatment of gynecological malignancies - analysis of a large patient cohort in a tertiary care center

Update Mammakarzinom 2024 Teil 1 – Expertenmeinungen zu Brustkrebs in fortgeschrittenen Krankheitsstadien = Update breast cancer 2024 part 1 – expert opinion on advanced breast cancer

Diagnostic performance of additional imaging tests for staging purposes in a bicentric German series of low-risk early breast cancer patients

Solitary precaval right renal artery and bilateral double ureter in a patient with high-grade serous ovarian cancer

Update Breast Cancer 2023 Part 3 – Expert Opinions of Early Stage Breast Cancer Therapies

Update Breast Cancer 2023 Part 2 – Advanced-Stage Breast Cancer

Update Breast Cancer 2023 Part 1 – Early Stage Breast Cancer

Association between 21-gene-assay and detection of disseminated tumor cells in patients with early breast cancer: results from the IRMA trial

Characteristics, treatment patterns and survival of international federation of gynecology and obstetrics stage IV epithelial ovarian cancer - a population-based study

Diagnostic performance of additional imaging tests for staging purposes in a bicentric German series of low-risk early breast cancer patients

Evolving trends in the surgical therapy of patients with endometrial cancer in Germany: analysis of a nationwide registry with special emphasis on perioperative outcomes

Solitary precaval right renal artery and bilateral double ureter in a patient with high-grade serous ovarian cancer

The clinical relevance of the NATALEE study: application of the NATALEE criteria to a real-world cohort from two large German breast cancer centers

Tumor-free resection margin distance in the surgical treatment of node-negative squamous cell cancer of the vulva has no impact on survival: analysis of a large patient cohort in a tertiary care center

Update breast cancer 2023 Part 1 – early stage breast cancer

Update breast cancer 2023 Part 1: early stage breast cancer

Update breast cancer 2023 part 2 – advanced-stage breast cancer

Update breast cancer 2023 part 2: advanced-stage breast cancer

Update breast cancer 2023 Part 3 – expert opinions of early stage breast cancer therapies

Update breast cancer 2023 part 3: expert opinions of early stage breast cancer therapies

Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT

Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics – a retrospective analysis of a real world registry

Recurrence Score® result impacts treatment decisions in hormone receptor-positive, HER2-negative patients with early breast cancer in a real-world setting - results of the IRMA trial

Status of Sentinel Lymph Node Biopsy in Endometrial Cancer

Status of sentinel lymph node biopsy in endometrial cancer = Stellenwert der Sentinellymphonodektomie beim Endometriumkarzinom

Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis

Das männliche Mammakarzinom : Vergleich der diagnostischen Wertigkeit von Palpation, Sonografie und Mammografie

Die laparoskopische suprazervikale Hysterektomie mit und ohne Peritonealisierung

Update Breast Cancer 2018 (Part 1) – Primary Breast Cancer and Biomarkers

Gynäkologische Onkologie : Prolog für die DKG: Olaf Ortmann, Geleitwort für die DGS: Rüdiger Schulz-Wendtland, Prolog für die AGO: Tanja Fehm

Detection and clinical relevance of hematogenous tumor cell dissemination in patients with ductal carcinoma in situ

Benign and Borderlinelesions of the myometrium : dissecting the clinical phenotype and developing new diagnostic and therapeutic tools

Expression der Mismatch-Reparatur-Proteine und Mikrosatelliteninstabilität in Urothelkarzinomen